Imperial Recognized as 2025 Best & Brightest Company to Work For in West Michigan! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Tag:

Global Clinical Trials Trends

    Life-Science Events

    OECT Summit: A Report From Germany

    by Imogen Cheese April 4, 2019
    written by Imogen Cheese

    My Imperial colleague Dan McDonald and I had a whirlwind visit across Europe recently. We visited numerous clients in different countries, and our trip culminated with our attendance at the Operational Excellence in Clinical Trials (OECT) Summit in Frankfurt, Germany on March 14 and 15.

    After a hectic start to our week, with several very early flights, lots of turbulence and a string of canceled flights; we were very much looking forward to having our feet on the ground and the chance to network with familiar and new faces.

    The OECT conference brings together clinical operations executives from a number of countries, especially European, to discuss challenges facing the industry in conducting clinical trials efficiently. While a variety of relevant subjects were covered, there was a particularly strong focus on the issue of delayed trial enrollment and the important role that patient recruitment/engagement has in addressing this age-old problem. While we found all presentations to be timely, interesting, and relevant, there were a few that stood out.

    Marta Garcia Manrique, clinical research director for Servier in the U.K., presented Servier’s major initiative to develop a “patient-in” mindset and operating model. She spoke about the significant effort that is going into influencing a cultural change at the company that will permeate into their clinical trial operating environment. Their view of the patient as a critical partner in the clinical research process is both needed and refreshing. Their approach is detailed and multifaceted according to Marta. She highlighted the need for the buy-in and support from senior and influential company executives and the trickle-down effect they can cause. She also mentioned that this movement is not optional and is transversal across study teams. And that active listening is required in order to develop patient-centric trials and/or support systems for study participants.

    I hope to see Marta down the road to learn how the rollout has progressed and I wonder if this is a replicable model that might be shared in the future. It is certainly exciting to hear of an approach that puts patient-centricity at the forefront of its business goals.

    Frank Berger, head of study budget for Boehringer Ingelheim – Germany, gave an interactive and engaging presentation about monitoring and tracking budget planning. This included how to spot where budgets have gone awry and how to predict where issues might arise.

    When a study fails, much of the focus or blame falls to the protocol being poorly designed or the CRO failing to recruit patients. This makes it appear that the concentration of budget misalignment would be at the start or at the end of the process. Frank’s thought process and methods of analysis displayed techniques to monitor and track with far greater accuracy. By following through each activity that takes place during study initiation, you can understand the cost drivers and improve budget accuracy and spend points far more efficiently.

    It’s always refreshing to attend small to medium-size conferences like the OECT where presentations are much more engaging. Discussion gets promoted, and as Frank showed and encouraged with his use of a flipchart placed in front of his slides, if your perspective changes, you can get a greater perception of the issues at hand.

    My colleague Dan McDonald, vice president at Imperial Clinical Research Services, presented findings from a survey undertaken by Imperial that collected feedback from over 400 COMs at sponsor companies. The survey looked at their roles and responsibilities, what barriers they face, and how patient recruitment fits within their roles.

    The resulting data that Dan shared was insightful. So often the people who we and others in the industry see as being the most influential in the area of study recruitment feel the least capable of affecting and influencing recruitment.

    We are all familiar with initiatives in patient engagement, including shiny and exciting innovations, the use of technology, and direct interaction with patients. But all too often these initiatives are rarely introduced in favor of the familiar, commonplace, and not always cost-effective solutions. We stick to what we know and we don’t challenge the status quo.

    That’s why conferences like OECT are so effective. The conversations and dialogue are not just tick boxes or for speakers to obtain kudos at large industry events. We heard about current issues, how other companies are overcoming hurdles, and then we had plenty of opportunities to analyze, question, and challenge.

    We look forward to being involved in many more of these interactive discussions in 2019 and beyond!

    April 4, 2019 0 comment
    0 FacebookTwitterLinkedinEmail

Welcome

Welcome

The Imperial blog features content of interest to life-science professionals, with a special focus on clinical trials. We hope you will enjoy our experts’ perspectives, and invite you to join the conversation by leaving your comments. Please let us know of any additional topics you would like to see covered here.

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email RSS

Popular Posts

  • 1

    See Do Get

    August 12, 2014
  • 2

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    Clinical Trial Supply Chains: The Key to Avoiding Disruptions

    May 10, 2022

Categories

  • Ancillary Trial Supplies and Equipment (28)
  • Business Insights (124)
  • Clinical Trial Writing and Design (36)
  • Life-Science Events (50)
  • Patient Engagement (30)
  • Patient Recruitment and Retention (93)
  • Site Materials & Logistics (44)
  • Study Site Management (21)
  • Translation of Study Materials (17)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribe to our blog and get the latest updates, insights, and industry trends delivered straight to your inbox. Stay informed and never miss a post.